Current status: 898 hESC lines, 4286 hiPSC lines, and 119 clinical studies, and 1119 certificates
Monthly statistic from Jul 1, 2023
Posted on July 1, 2023
total lines | 5184 |
hESC lines | 898 |
hiPSC lines | 4286 |
derivation countries | 46 |
projects | 273 |
providers | 822 |
clinical studies | 119 |
subclones | 2173 |
certificates | 1119 |
cell line certificates | 980 |
project certificates | 139 |